2675677
SBDFP · Branded drug packinfluenza A virus A/California/122/2022 (H3N2) antigen / influenza A virus A/Victoria/4897/2022 (H1N1) antigen / influenza B virus B/Michigan/01/2021 antigen / influenza B virus B/Phuket/3073/2013 antigen Injectable Suspension [Fluzone Quadrivalent 2024 Southern Hemisphere]
Concept
Cross-maps
Synonyms
No additional synonyms recorded.
Related concepts
Common questions
What is the RxNorm code for influenza A virus A/California/122/2022 (H3N2) antigen / influenza A virus A/Victoria/4897/2022 (H1N1) antigen / influenza B virus B/Michigan/01/2021 antigen / influenza B virus B/Phuket/3073/2013 antigen Injectable Suspension [Fluzone Quadrivalent 2024 Southern Hemisphere]?
influenza A virus A/California/122/2022 (H3N2) antigen / influenza A virus A/Victoria/4897/2022 (H1N1) antigen / influenza B virus B/Michigan/01/2021 antigen / influenza B virus B/Phuket/3073/2013 antigen Injectable Suspension [Fluzone Quadrivalent 2024 Southern Hemisphere] is coded as 2675677 in RxNorm.
What is RxNorm code 2675677?
2675677 is the RxNorm identifier for influenza A virus A/California/122/2022 (H3N2) antigen / influenza A virus A/Victoria/4897/2022 (H1N1) antigen / influenza B virus B/Michigan/01/2021 antigen / influenza B virus B/Phuket/3073/2013 antigen Injectable Suspension [Fluzone Quadrivalent 2024 Southern Hemisphere]. It is included in the current monthly NLM RxNorm release.
What term type is RxCUI 2675677?
2675677 is a SBDFP (Branded drug pack) in RxNorm.
What is the UMLS mapping for 2675677?
2675677 maps to UMLS C5888532.